Defence Therapeutics Financial Overview
Defence Therapeutics's market cap is currently C$43.23M. The company's EPS TTM is C$; its P/E ratio is -11.16; Defence Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.